Masitinib mesylate fadoxine orally active

orally active

ClH/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3

Activity-Guided Design ofHDAC11-Specific Inhibitors

2-dihydroisoquinolin-6-yl)-2-(thiophen-3-yl)acetamide

is an orally available cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity

Masitinib mesylate fadoxine orally activeMasitinib Mesylate is a potent and selective tyrosine kinase inhibitor that targets KIT. Product information CAS Number: 1048007 93 7 Molecular Weight: 594. 75 Formula: C29H34N6O4S2 Chemical Name: N (4 methyl 3 {[4 (pyridin 3 yl) 1,3 thiazol 2 yl]amino}phenyl) 4 [(4 methylpiperazin 1 yl)methyl]benzamide; methanesulfonic acid Smiles: CN1CCN(CC2=CC=C(C=C2)C(=O)NC2C=C(NC3=NC(=CS3)C3=CC=CN=C3)C(C)=CC=2)CC1. CS(O)(=O)=O InChiKey: TXCWBWKVIZGWEQ UHFFFAOYSA